Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Outperformance during the fourth quarter primarily resulted from stock selection and an overweight in industrials. Read more ...

Baron Funds, an investment management company, released its “Baron ... December 05, 2024--ICON announces results from a global survey of biopharma professionals on AI and digital innovation ...

Brandscouncil Ratings felicitated 100+ Corporates with World Best Brands & Business Awards'2024, World Real Estate, Constructions & Infrastructure Awards 2024, World Healthcare Awards 2024, GFSTIIA ...

"Through remembering the dead to fight like hell for the living - we act up and fight back!" writes Dan Glass of his response ...

NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / WHY: New York, N.Y., February 12, 2025. Rosen Law Firm, a global investor rights law ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...

WASHINGTON (Reuters) -Republican U.S. House of Representatives Speaker Mike Johnson said on Wednesday that he believes ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Amgen has been a biotechnology pioneer since 1980. The global pharma company's ongoing mission is "to serve patients" and one way to complete this mission is by keeping up-to-date with the latest ...